Rise Advisors’s CME Group CME Stock Holding History

Rise Advisors’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-220	Closed	-$59.4K	–	361
2025 Q3	$59.4K	Buy	220 +4	+2%	+$1.09K	0.02%	224
2025 Q2	$59.5K	Buy	216 +1	+0.5%	+$272	0.02%	211
2025 Q1	$57K	Buy	215 +18	+9%	+$4.44K	0.03%	209
2024 Q4	$45.8K	Buy	197 +3	+2%	+$690	0.02%	251
2024 Q3	$42.8K	Buy	194 +1	+0.5%	+$207	0.02%	272
2024 Q2	$38K	Buy	193 +1	+0.5%	+$207	0.02%	294
2024 Q1	$41.3K	Buy	+192	New	+$40.3K	0.02%	261

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Rise Advisors's CME Position: Q4 2025 in Review

Rise Advisors sold out of CME Group (CME) in Q4 2025, closing a stake of 220 shares — an estimated $59.4K sold.

Rise Advisors first reported a position in CME in Q1 2024 and held it in 7 quarters. The position peaked at $59.5K in Q2 2025. 1,736 funds tracked by Wall St. Rank hold CME as of Q4 2025.

Rise Advisors reported no remaining CME Group position as of Q4 2025 after selling out during the quarter.
Rise Advisors sold 220 CME Group shares in Q4 2025, an estimated $59.4K.
Rise Advisors first reported a position in CME Group in Q1 2024 and held it in 7 quarters.
Rise Advisors's CME Group position peaked at $59.5K in Q2 2025.
1,736 funds tracked by Wall St. Rank held CME Group as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.